May 8, 2025: Washington, DC – Today, the National Consumers League (NCL) released results from a new Morning Consult national poll of more than 10,000 American adults, revealing overwhelming concern about the burden of medical debt and strong public demand for comprehensive reforms of the 340B Drug Pricing Program. Nearly four in five surveyed adults (78%) support establishing requirements to ensure that qualifying patients directly benefit from 340B drug discounts through reduced out-of-pocket prescription drug costs. More than three in four surveyed adults (77%) believe hospitals should be required to pass 340B savings directly onto patients.

May 1, 2025: Washington, DC – The National Consumers League (NCL) applauds Senator Bill Cassidy, M.D. (R-LA), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, for releasing a new report exposing significant accountability gaps in the federal 340B drug discount program.    

May 1, 2025: Washington, DC – With mounting evidence that an infodemic of disinformation about GLP-1 weight loss medicines has become America’s second obesity crisis, the National Consumers League (NCL) – a leading non-profit fighting fraud in the marketplace – today released a white paper as a blueprint for policy changes to combat the flood of false information circulating online about GLP-1 products and launched an ambitious national anti-disinformation effort called the Weight Truth with the online hub, www.weight-truth.org, to drive action.

April 22, 2025: Washington, DC – The National Consumers League (NCL) is raising serious concerns about the Trump administration's proposal to cut the Department of Health and Human Services (HHS) budget by more than 30%. This drastic move would gut essential public health protections, weaken food safety, and threaten scientific progress.

April 18, 2025: This week, the National Consumers League this week strongly recommended expanding respiratory syncytial virus (RSV) vaccines for high-risk adults 50-59 years old to protect against a condition that can become severe for infants and older adults. NCL was selected to make remarks before the critically important Advisory Committee on Immunization Practices ( ACIP)  Additionally, NCL encouraged the Committee to continue its work in support of increasing vaccine confidence and transparency for the public.  On April 11, 2025, the National Consumers League submitted comments in response to a request for comments at the April 15 and 16 in Atlanta, Georgia.

March 27, 2025: Washington, DC – The National Consumers League (NCL) is deeply concerned by the Trump administration's decision to lay off an additional 10,000 employees at the Department of Health and Human Services (HHS) following the already eliminated 10,000 jobs via previous rounds of cuts. In total, the restructuring and force reduction plans will result in a downsizing from 82,000 to 62,000 full-time employees nationwide.

March 13, 2025: Washington, DC — As of this week, there are a total of 223 cases of measles in western Texas, and it is spreading to neighboring counties in New Mexico and Oklahoma. Yet, recently confirmed Secretary of U.S. Health and Human Services Robert F. Kennedy is not actively pushing for Americans to get immunized. The National Consumers League (NCL) stands firmly on the side of science and evidence-based medicine.  In February, we expressed concern over his appointment, and now we are witnessing the significant risk to Americans' health and well-being we previously stated. 

March 12, 2025: Washington, DC – Millions of Americans would be affected by the Trump administration's attempts to shorten the Affordable Care Act (ACA) open enrollment period and eliminate the monthly enrollment option for low-income families.   

February 25, 2025: Washington, DC – The National Consumers League (NCL) is proud to announce its support for the PBM Accountability Project’s letter, which has been shared with the U.S. House Energy & Commerce Health Subcommittee ahead of their hearing on February 26, 2025. The PBM Accountability Project calls for urgent reform of the Pharmacy Benefit Manager (PBM) industry to increase transparency, reduce prescription drug costs, and provide relief to consumers and patients across the nation.    

February 20, 2025: Washington, DC – The National Consumers League (NCL) acknowledges the intention behind the establishment of the Make America Healthy Again (MAHA) Commission and supports efforts to address the growing concerns around chronic disease in America, particularly those impacting our children. We look forward to collaborating with the Commission to ensure that its findings and recommendations are rooted in rigorous, evidence-based science that reflects modern-day understanding and research. 

February 20, 2025 : Washington, DC – The National Consumers League (NCL) applauds the U.S. Food and Drug Administration (FDA) for approving Journavx, a pioneering non-opioid analgesic for treating moderate to severe acute pain in adults. This approval introduces a promising alternative to opioids in pain management, addressing the urgent need for safer treatments amid the ongoing opioid crisis. 

February 19, 2025: “We’re not going back” is a rallying cry not usually associated with food safety policy. But if the Trump Administration heeds the call from the trade association for the processed meat industry to withdraw a needed proposed food safety rule, Americans will indeed go back to facing preventable foodborne illness outbreaks. 

February 13, 2025: Washington, DC – The National Consumers League (NCL), a long-time advocate for consumer health and safety, is disappointed with the Senate's confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services (HHS), which oversees agencies such as the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH). NCL has consistently supported science, evidence-based medicine, and public health and believes this appointment poses a significant risk to Americans' health and well-being. Kennedy, who holds a law degree and has no medical training, is uniquely unqualified for this role.  

February 5, 2025: Washington, DC – Today, the National Consumers League (NCL) joined over 25 patient and provider advocacy organizations in voicing strong opposition to the proposed expansion of the 340B Drug Pricing Program under NY Senate Bill 1913.

February 4, 2025: Washington, DC –  As an organization with a long history of helping the public avoid fakes and unregulated products, the National Consumers League is urging consumers and health professionals to heed the warning from the Food and Drug Administration that compounded versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs now widely promoted on television and online are not FDA approved and may cause serious health problems.

January 17, 2025: Year in and year out, for over a decade, advocates and obesity specialists worked to get changes in federal policy. They pressed to get bills passed in Congress, drafted white papers, published research findings in medical journals, held roundtables and briefings, and sent letters and emails to policymakers over and over. But, using the Groundhog Day metaphor, the same day would start again.

January 13, 2025: Washington, DC – We, the undersigned organizations, are enthusiastically supportive of the proposed rule by the Centers for Medicare & Medicaid Services (CMS) to align coverage policy to reflect the prevailing medical consensus that obesity is a chronic disease.

January 7, 2025: Washington, DC – Today, the Consumer Financial Protection Bureau (CFPB) finalized a rule to stop the harmful impact of medical debt on consumers’ credit scores.

January 6, 2025: Washington, DC – The National Consumer League (NCL) has released a new episode of its We Can Do This podcast, shedding light on the inequities and lack of transparency surrounding the 340B Drug Pricing Program

January 6, 2025: On this episode of NCL’s “We Can Do this” podcast, National Consumers League CEO Sally Greenberg speaks with Amy Hinojosa, President and CEO of Mana, a National Latina Organization, and Dr. Ge Bai, an expert on health care accounting, finance, and policy at Johns Hopkins University, regarding a shocking lack of transparency for a program that has more than doubled in cost reaching more than $120 Billion in 2022.

In terms of the number of people it affects and the serious health…

December 18, 2024: The National Consumers League (NCL) recently published a new issue brief focused on hospital’s medical debt practices. With over 100 million Americans grappling with medical debt, and 1 in 7 of them reporting to KFF Health News that they’ve been denied care, it is prudent to evaluate these anti-consumer hospital policies.

For more than a century, the National Consumers League (NCL)…

The drive to achieve accessible, affordable, high-quality healthcare…

December 6, 2024: Today, over 100 million Americans, or 40.3 percent of adults, are living with obesity. This makes obesity the nation’s most widespread chronic condition, impacting many more people than diabetes, heart disease, stroke, certain cancers, chronic lung disease, and chronic kidney disease.

November 26, 2024: Washington, DC – The National Consumers League (NCL) applauds the action by President Joe Biden to allow millions of Americans on Medicare and Medicaid to have coverage for new and very effective anti-obesity medicines (AOMs), thereby removing one of the biggest obstacles impeding access to quality obesity care in the country.

November 26, 2024: Washington, DC— In response to recent media coverage about Robert F. Kennedy Jr. and Florida Surgeon General Joseph A. Ladapo campaigning against water fluoridation, Sally Greenberg, CEO of the National Consumers League (NCL), issued the following statement: “Robert F. Kennedy Jr.’s statements on fluoride could jeopardize a proven public health measure. Consumers are best served by reliable, evidence-based health information, not alarmist misinformation.”

November 15, 2024: Greenberg, NCL CEO testifies at the FDA about Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to less than 12 Years of Age.

November 15, 2024 Media contact: National Consumers League…

October 30, 2024: Consumers, unfortunately, accrue debt quite often throughout their lives – be it a mortgage, a car loan, credit cards, or even student loans. However, there is one type of debt that consumers have no way of knowing when it will be incurred – medical debt.

October 29, 2024: NCL’s Health Director, Robin Strongin, released the following statement regarding Walt Bogdanich and Carson Kessler’s October 23 article, Health Section, New York Times, “What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials,” which reported that pharmaceutical companies withheld genetic testing information from volunteers in Alzheimer’s trials putting them at risk for brain bleeds.  

October 21, 2024: Now that we are a mere 15 days away from the election, all attention is unsurprisingly laser-focused on the outcome of the general election.

September 20, 2024: The National Consumers League today applauds the Federal Trade Commission for bringing action against the three largest prescription drug benefit managers and affiliated group purchasing organizations.

September 20, 2024: Americans need and now have an Obesity Bill of Rights for a reason: People with obesity do not receive the same concern, level of attention, and quality care as those with any other serious chronic disease.  

July 23, 2024: The National Consumers League today submitted a letter to both the Republican and Democratic chairs of the House Committee on Oversight and Accountability expressing concerns about pharmacy benefit managers driving the increase in out-of-pocket healthcare costs for Americans.

July 2, 2024: For two years now reproductive justice – as a term, a framework, and an ideal – has been thrust into the mainstream.

March 6, 2024: Every year, the calendar is full of national health observances – special months, weeks and days that raise awareness of serious diseases and health issues. While all are valuable to advance the health of the Americans, Obesity Care Week taking place March 4-8 is especially significant.

February 23, 2024: The federal 340B drug discount program is a worthy and critical program. Created by Congress in 1992, it mandates that pharmaceutical manufacturers participating in the Medicaid program must offer prescription medicines at discounted rates to community health centers and safety-net hospitals serving low-income and uninsured patients.

January 25, 2024: Copycat versions of expensive drugs may look the same, but the impact on consumer pocketbooks is far from identical

December 8, 2023: Consumers have known for quite some time now that the prescription drug pricing system is essentially a black box.

October 18, 2023: NCL is excited to present the inaugural podcast episode of our new Health Podcast Series under the “We Can Do This!” podcast umbrella, hosted by our Senior Director of Health Policy Robin Strongin. This month we are celebrating National Hispanic Heritage Month with our esteemed guest Amy Hinojosa, National President & CEO of MANA.

With growing evidence that U.S. adults with obesity feel stigmatized and ignored by their health care providers, the National Consumers League (NCL) and National Council on Aging (NCOA) today urged health professionals, insurers and employers to join a national movement to define quality obesity care as a right for every American.

October 2, 2023: The past few decades have seen dramatic changes in the food environment and food behaviors, all resulting in the epidemics of obesity and diet-related chronic diseases.  About 72% of American adults are overweight or obese and more than half have diet-related chronic diseases. Our research shows that the food environment actually encourages people to eat impulsively and markets twice as much food as people need to maintain a healthy weight.

September 18, 2023: In 1992, Congress created the 340B Drug Pricing Program to help ensure vulnerable patients would be able to access medications they need but may not be able to afford. This program provides steeply discounted drugs to health care providers – mostly hospitals – serving low-income patients with the intent that the providers would pass those discounts along to patients. Unfortunately, that is not what is happening. The National Consumers League (NCL) is increasingly concerned about this program, especially as it relates to hospitals’ abusive and aggressive debt collection practices, and how those practices lead to consumer medical debt.

The NCL applauds the FDA’s announcement approving the latest COVID vaccine, which will be available to many Americans immediately or very soon to patients who are eligible.

August 25, 2023: Washington, DC – On August 17, the National Consumers League responded to the Request for Information regarding FDA-Regulation of CBD.

August 11, 2023: Employers seeking to cut healthcare costs should remember this simple rule of thumb: If an offer to save money seems too good to be true, it usually is. That seems to be the case with offers to try “Alternative Funding Programs” or AFPs.  This is a devious but growing cottage industry, which promises to cut employer costs for specialty medicines. 

July 27, 2023: When I started my National Consumers League (NCL) internship in May 2023, I quickly dove into NCL’s health policy work. NCL is leading on several efforts to protect consumers –one area of focus that stood out to me is their work in the cannabis policy space. NCL is a founding member of Cannabis Consumer Watch (CCW), which educates consumers on cannabinoids, their effects, the risks related to the unregulated marketplace, and the ways policymakers and regulators can help protect consumers.

The National Consumers League (NCL) welcomes the reintroduction  of the Treat and Reduce Obesity Act (TROA) as a needed step to end outdated Medicare rules that leave millions of seniors with diagnosed obesity – particularly members of Black and Latino communities – vulnerable to disability, disease and premature death due to lack of access to the full range of treatment options.

July 12, 2023: My husband has advanced Lewy Body Dementia and one of the few things we can still enjoy together is listening to music.  We used to curate playlists for all kinds of music. We even put together playlists to mark special occasions (like our daughter’s wedding).  Really, any topic became fair game for a playlist. I was invited to speak at the Patients Rising Disrupting Healthcare Summit summer conference in Washington DC.  My panel topic was Financing the Healthcare of Tomorrow.

June 21, 2023: I have written before about being born into a family that experienced the agony of the polio epidemic. My uncle Roger Joseph’s battle with the disease—including his diagnosis in 1951 by my father, a practicing internist—devastated our entire family.

May 16, 2023: Today, the National Consumers League (NCL) announced the winners of its twelfth annual Script Your Future Medication Adherence Team Challenge, an eight-week intercollegiate competition among health profession student teams and faculty to combat poor medication adherence in the United States, where nearly three out of four patients do not take their medication as directed.

This week, researchers from the Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, Food and Drug Administration (FDA) published an analysis on the toxicity of cannabidiol (CBD). The National Consumers League (NCL), the nation’s oldest consumer advocacy organization, has been actively monitoring the growing threats to consumer safety as the market for untested, unapproved cannabidiol (CBD) products has exploded.

President Biden has proposed significant funding for a historic national Hepatitis C elimination program. “President Biden’s efforts to create a mandatory national program to expand testing, treatment, and prevention of Hepatitis C is a major step forward in eradicating a disease for which we have a cure.” said Robin Strongin, NCL’s Health Policy Director. 

March 15, 2023: Here we go, again. Up until the Dobbs decision in 2022, Roe v Wade had been the law of the land since 1973. Up until today, women didn’t have to worry that mifepristone, approved by FDA in 2000, would be available as a safe and effective and legal way to end an early pregnancy.

NCL’s Executive Director Sally Greenberg spoke at the Association of Accessible Medicines and International Generic and Biosimilar Medicines Association Annual Meeting in Orlando, FL on Wednesday, February 15, 2023. Greenberg joined the panel “The Generic and Biosimilar Industries Global Reputation” moderated by former NY Times journalist Gardiner Harris.

“What we’ve got here is a failure to communicate.” As one of the most recognized quotes of all time, this line from the 1967 movie, Cool Hand Luke, originally addressed the struggle of a person’s will over government control. Now the line is applicable to another and equally intractable struggle: ending outdated Medicare rules that leave millions of seniors with diagnosed obesity – particularly members of Black and Latino communities – vulnerable to disability, disease and premature death due to lack of access to the full range of treatment options.

Pregnancy discrimination in the workplace is real and it’s dangerous.  But, if the Senate acts quickly, it can pass S. 4431, the Pregnant Workers Fairness Act (PWFA) which provides reasonable accommodations for pregnant and postpartum workers.

Today, the U.S. Food and Drug Administration (FDA) issued its final rule enabling access to over-the-counter hearing aids for consumers with perceived mild to moderate hearing loss. National Consumers League (NCL) strongly supports expanding access to and affordability of hearing aids.

The National Consumers League (NCL) today released A New Patient-Centered Obesity Action Agenda: Changing the Trajectory of Obesity Through Patient Empowerment, Health Professional Intervention and Supportive Government Policies, a new report with a blueprint to change how Americans think about obesity, empower people with obesity to get the best care, and afford those with obesity the same access to care as adults with other serious chronic diseases.

Sally Greenberg sits down with members of the African American Tobacco Control Leadership Council, the country’s leading public health education and advocacy organization taking on Big Tobacco to save Black lives.

Many of us take for granted that our medicines are available at the pharmacy whenever needed. Despite the disruptions of the pandemic, U.S. healthcare supply chains remained incredibly resilient, safe and reliable.

Mild to moderate hearing loss is a difficult reality that millions of Americans struggle with, which is why the availability of over-the-counter (OTC) hearing aids is exciting for those who are impacted by hearing loss. While making OTC hearing aids more accessible is a promising step for consumers, we at NCL would be remiss if we didn’t underscore our concerns around the Food and Drug Administration’s (FDA) proposed OTC hearing regulations as they currently exist.

The rising cost of health care is a sore point for all consumers and nowhere is it more glaring than at the pharmacy counter. However, consumers are largely unaware that Pharmacy Benefit Managers – or PBMs – are the middlemen working behind the scenes with very little competition and accountability.

Happy Consumer Protection Week! Are you an online shopper? This podcast is for you!

A lack of diversity in the health care workforce has been a persistent issue in the United States, posing significant implications to health equity, particularly for the Black or African American community.

This episode contains sensitive topics, such as abortion and sexual violence, that may be difficult for some audiences. Listener discretion advised. As listeners of our podcast know, the National Consumers League believes in equal health care access for all, and that includes a woman's right to choose.

We, as consumers — at the touch of a few buttons — have access to drugs and devices that would have required far more time and effort to acquire in the past. But with that ease of access, we also have millions of tainted or suspect products peddled to consumers, including counterfeit drugs.

Advocates are welcoming enforcement action by FTC and DOJ to end the deceptive marketing of contact lenses by Vision Path, which put consumers at risk by failing to obtain proper prescriptions, to properly verify prescription information, and by substituting Hubble lenses for those actually prescribed to consumers.

More than half of U.S. consumers reported recently receiving an unexpected medical bill. The No Surprises Act will help.

It is no surprise that people of color in the United States have less access to the care they need and have more health complications. This is true for reproductive care and family planning.

The FDA has proposed making hearing aids available as an OTC. But advocates are concerned that the regulations aren't exactly right when it comes to thresholds for volume.

Healthcare continues to be front and center in the national discourse, particularly in the midst of the pandemic. As Congress works on policy solutions to lower healthcare costs for consumers, we face an unfair disadvantage when it comes to what we’re paying at the pharmacy counter.

During the pandemic, we have seen routine vaccination rates decline significantly across all populations, putting individuals at risk of contracting vaccine-preventable diseases.

As we commemorate Hispanic Heritage Month, the National Consumers League (NCL) wants Latino consumers to better understand their health coverage options through the Health Insurance Marketplace.

CBD-infused foods and candies are often packaged and marketed to appeal to children, but buyer beware – there are a number of harmful ingredients that could be in a seemingly harmless gummy bear. Parents, teachers, guardians, and loved ones should know that none of the non-prescription CBD products on the market today – and the false medical claims often used to market these to consumers – have been tested or approved by the FDA.

Even more illuminating, one of the best predictors of health outcomes is a person’s zip code. In many major U.S. cities, the gap in life expectancy between the highest and lowest zip codes is 20+ years.

I was tired of feeling like the virus was winning. I was sick and tired of feeling at the mercy of the whims of this unrelenting, mutating disease. I was angry that this pandemic was beating the hell out of us. So despite any fears and reservations I had about a new vaccine, I was ready to fight.

The collection and use of real-world research and data to inform the potential use, risks, and benefits of medical products and treatments can ultimately lead to better health outcomes, particularly for those who have been underrepresented in the past.

Even though there is overwhelming evidence in support of the COVID-19 vaccines and their safety, vaccine hesitancy still looms.

There’s still time to get marketplace coverage and expanded financial assistance through August 15.

2020 saw a 10 percent increase in gun deaths over the previous year, fueled primarily by a 25 percent rise in homicides and accidental gun deaths. Experts say the recent spike is due to the economic and social stresses of the pandemic, and the numbers are showing no signs of abating as we open back up post-COVID.

Research shows that LGBTQ individuals who live in communities with high levels of anti-LGBTQ prejudice die sooner—12 years on average—than those living in more accepting communities. Queer and Trans people of color (QTPOC) face even higher rates of fatal violence, as 44 transgender and gender non-conforming people died to anti-trans violence in 2020.  

In the last few weeks, I’ve noticed an old friend from high school, a mother of an infant, consistently posting anti-vaccine content to her social media. Her posts, which were initially mere reflections, have transformed into full-on conspiracy theories about the safety of the COVID-19 vaccines and cast doubts about to the speed of their approval.

The AAPI community’s resilience against these factors, while commendable, has contributed to the myth of the “Model Minority,” and has led to a host of social and health inequities.

Tras la efectiva campaña de vacunación, las pruebas de detección serán claves para seguir evitando contagios del coronavirus y resumir a la normalidad.

COVID-19 testing has been a critical component of the nation’s pandemic response...

The new Preterm Birth Prevention Alliance brings together a coalition of 15 patient advocacy organizations who share concerns about the grave state of preterm birth in the United States and its disproportionate impact on Black, Indigenous, and women of color.

If the pandemic has taught us anything, it’s that threats to our health care system can change lives...

When we go to the pharmacy for our medications, we expect a fair price. However, there’s growing evidence that pharmacy benefit managers — or PBMs — have been impeding the savings that should be going to consumers.

The COVID-19 pandemic has enlightened us to how the social determinants of health adversely impact maternal...

A variety of factors drive drug costs, some of which are obvious: the cost of research and development, distributing the product, the pharmacies’ profits – but there is one far less known cause of price increases: PBMs, short for pharmacy benefit managers.

Gracias a la autorización de la nueva vacuna, presidente Biden afirma que para el fin de mayo habrá vacunas para todos los adultos en EEUU.

Current CDC guidance states that even if you’ve recovered from COVID-19, you should get vaccinated.

COVID-19 has exposed the fact that conditions in the environments in which people are born, live, learn, work, play, worship, and age threaten to impede access to the vaccine.

While the variants all differ slightly in their function, they all possess a specific mutation called D614G — a shared trait that allows these new strains to spread more quickly than the predominant virus.

Over the course of the pandemic, mask-wearing has unfortunately morphed into a highly polarizing political issue. But the President's new EO makes it very clear.

There’s light at the end of the tunnel because, in record time, America’s pharmaceutical companies have successfully developed safe and highly effective vaccines.

Most people would agree that coronavirus has worn our country down, and experts have a new fear: that "caution fatigue" is causing a spike in cases.

Most people would agree that coronavirus has worn our country down, and experts have a new fear: that "caution fatigue" is causing a spike in cases.

From November 1, 2020 to December 15, 2020, consumers will be able to enroll in health coverage through the health insurance marketplace, Healthcare.gov.

Implementing a vaccine program of this magnitude is contingent upon precise coordination that traverses federal, state, local, tribal, and territorial governments.

You may never have heard of hydroxyprogesterone caproate or “17P”—it’s a mouthful, but the role it has played in the lives of thousands of pregnant mothers and babies is easy to understand.

Hispanic Heritage Month: Focus on the importance of participating…

You may never have heard of hydroxyprogesterone caproate or “17P”—it’s a mouthful, but the role it has played in the lives of thousands of pregnant mothers and babies is easy to understand.

By NCL Health Policy intern Talia Zitner Around the globe, researchers…

By Nissa Shaffi, NCL Associate Director of Health Policy On…

By Nailah John, Linda Golodner Food Safety and Nutrition…

By Nailah John, Linda Golodner Food Safety and Nutrition…

By Sally Greenberg, NCL Executive Director In a perfect world,…

By Nailah John, Linda Golodner Food Safety and Nutrition Fellow Overeating…

By Nailah John, Linda Golodner Food Safety and Nutrition Fellow While…

Media contact: National Consumers League – Carol McKay, carolm@nclnet.org, (412) 945-3242 or Taun Sterling, tauns@nclnet.org, (202) 207-2832 Washington, DC—The National Consumers League (NCL), the nation’s pioneering consumer advocacy organization, expresses concern about the Trump Administration’s Notice of Benefit and Payment Parameters Rule for 2021.

By Sally Greenberg, NCL Executive Director While all of us have…

By Nissa Shaffi, NCL Associate Director of Health Policy The…

By Nailah John, Linda Golodner Food Safety and Nutrition…

May 8, 2020 Watch recording here Contact:…

By Sally Greenberg, NCL Executive Director COVID has changed…

By Sally Greenberg, NCL Executive Director What a bittersweet…

By Nissa Shaffi, NCL Associate Director of Health Policy As…

Reid Maki is the director of child labor advocacy at…

By Sally Greenberg, NCL Executive Director At the National Consumers…

By Nailah John, Linda Golodner Food Safety and Nutrition Fellow In…

By Sally Greenberg, NCL Executive Director During…

By Nailah John, Linda Golodner Food Safety and Nutrition Fellow The…

By Nissa Shaffi, NCL Associate Director of Health Policy Ten…

March 27, 2020: A message to our online community about how…

By Nailah John, Linda Golodner Food Safety and Nutrition…

I spent a week last month in Boise with two members of the staff…

By Nailah John, Linda Golodner Food Safety and Nutrition Fellow Social…